Adage Capital Partners
HCAT icon

Adage Capital Partners’s Health Catalyst HCAT Stock Holding History

Adage Capital Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-159,280
Closed -$722K – 889
2025
Q1 		$722K Buy
159,280
+85,000
+114% +$450K ﹤0.01% 804
2024
Q4 		$525K Sell
74,280
-50,000
-40% -$398K ﹤0.01% 837
2024
Q3 		$1.01M Sell
124,280
-74,683
-38% -$540K ﹤0.01% 801
2024
Q2 		$1.27M Hold
198,963
– – ﹤0.01% 797
2024
Q1 		$1.5M Buy
+198,963
New +$1.82M ﹤0.01% 782

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners's HCAT Position: Q2 2025 in Review

Adage Capital Partners sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 159,280 shares — an estimated $722K sold.

Adage Capital Partners first reported a position in HCAT in Q1 2024 and held it in 5 quarters. The position peaked at $1.5M in Q1 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Adage Capital Partners reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Adage Capital Partners sold 159,280 Health Catalyst shares in Q2 2025, an estimated $722K.
  • Adage Capital Partners first reported a position in Health Catalyst in Q1 2024 and held it in 5 quarters.
  • Adage Capital Partners's Health Catalyst position peaked at $1.5M in Q1 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Adage Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.